Symbol
LIMN on Nasdaq
Investment type
Equity / Common Stock, par value $ 0.0001 per share
Latest Disclosed Shares Owned
6,900,000 shares
Security Ownership %
26%

Iris Acquisition Holdings LLC ownership in Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN)

08 May 2025 - Iris Acquisition Holdings LLC has filed an SCHEDULE 13D form with the Securities and Exchange Commission (SEC) disclosing ownership of 6,900,000 shares of Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN). This represents 26% ownership of the company. This is the first filing by Iris Acquisition Holdings LLC disclosing ownership of Liminatus Pharma, Inc. Common Stock, par value $ 0.0001 per share (LIMN).